1. Polymorphisms at long non-coding RNAs and prostate cancer risk in an eastern Chinese population.
- Author
-
Cao DL, Gu CY, Zhu Y, Dai B, Zhang HL, Shi GH, Shen YJ, Zhu YP, Ma CG, Xiao WJ, Qin XJ, Lin GW, and Ye DW
- Subjects
- Adult, Aged, Aged, 80 and over, Genotype, Humans, Male, Middle Aged, Odds Ratio, Risk Factors, Asian People genetics, Genetic Predisposition to Disease genetics, Polymorphism, Single Nucleotide genetics, Prostatic Neoplasms genetics, RNA, Long Noncoding genetics
- Abstract
Background: Controversial data on the association of single-nucleotide polymorphisms (SNPs, rs3787016G>A and rs10773338G>A) in long non-coding RNA (lncRNA) with prostate cancer risk were emerged. Considering possible genetic differences among populations, we conducted the present study to clarify these discrepancies and re-validate these results in an eastern Chinese population and thus provide clues for new therapeutic targets of prostate cancer., Methods: Genotypes of these two SNPs from 1015 ethnic Han Chinese patients with prostate cancer and 1032 cancer-free controls were determined by Taqman assays. Logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for risk associations., Results: The association of rs3787016 A variant genotypes with a significantly higher prostate cancer risk were found (adjusted OR = 1.418, 95% CI = 1.090-1.844 for AA vs GG). Stratification analysis indicated that the risk of rs3787016 variant AG/AA genotypes was more evident in younger subjects, ever smoking, patients with Gleason score ⩾ 7(4+3) and highly aggressive status. All these risks were not present for rs10773338G>A., Conclusions: These findings suggested that lncRNA SNPs may contribute to prostate cancer risk in an eastern Chinese population. Larger and well-designed studies with different ethnic populations are warranted to validate our findings.
- Published
- 2014
- Full Text
- View/download PDF